These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7872816)

  • 1. [Intra-tissue biological markers in cancers of the breast: current assessment].
    Romain S; Spyratos F; Goussard J; Magdelenat H; Martin PM
    Arch Anat Cytol Pathol; 1994; 42(5):251-61. PubMed ID: 7872816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contribution of biology to the therapeutic decision: cancer of the breast in 1995].
    Chinot O; Romain S; Martin PM
    Bull Cancer Radiother; 1995; 82(2):225-37. PubMed ID: 7546893
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic factors in breast cancer patients].
    Roisman I; Peretz T; Reznick AZ; Lifshitz I; Bitterman A; Fares F; Toledano H; Barzilay A; Durst AL
    Harefuah; 1996 May; 130(10):693-9. PubMed ID: 8794662
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the tumor associated proteases cathepsin D (CATH D) and urokinase-type plasminogen activator (uPA) in cytosols of human breast cancer patients.
    Liebert A; Quietzsch D; Beier L
    Anticancer Res; 1999; 19(4A):2571-6. PubMed ID: 10470197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular prognostic factors for breast cancer metastasis and survival.
    Esteva FJ; Sahin AA; Cristofanilli M; Arun B; Hortobagyi GN
    Semin Radiat Oncol; 2002 Oct; 12(4):319-28. PubMed ID: 12382190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin-D in human breast cancer: correlation with vascular invasion and other clinical and histopathological characteristics.
    Hähnel R; Harvey J; Robbins P; Sterrett G
    Anticancer Res; 1993; 13(6A):2131-5. PubMed ID: 8297125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
    Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
    Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 9. [Breast cancer: prognostic value of a dissemination index based on 4 components of the urokinase-type plasminogen activator system].
    Bouchet C; Hacène K; Martin PM; Becette V; Tubiana-Hulin M; Lasry S; Oglobine J; Spyratos F
    Pathol Biol (Paris); 2000 Nov; 48(9):825-31. PubMed ID: 11141918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current aspects in histopathological assessment of breast cancer].
    Sastre X
    Bull Cancer; 1997 Jan; 84(1):65-8. PubMed ID: 9180862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors.
    Jahkola T; Toivonen T; von Smitten K; Virtanen I; Wasenius VM; Blomqvist C
    Br J Cancer; 1999 Apr; 80(1-2):167-74. PubMed ID: 10389993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical markers in breast cancer: which ones are clinically useful?
    Duffy MJ
    Clin Biochem; 2001 Jul; 34(5):347-52. PubMed ID: 11522269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlinear discriminant analysis and prognostic factor classification in node-negative primary breast cancer using probabilistic neural networks.
    Le Goff JM; Lavayssière L; Rouëssé J; Spyratos F
    Anticancer Res; 2000; 20(3B):2213-8. PubMed ID: 10928180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.
    Ioachim EE; Athanassiadou SE; Kamina S; Carassavoglou K; Agnantis NJ
    Anticancer Res; 1998; 18(3A):1665-70. PubMed ID: 9673387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour epidermal growth factor receptor, erbB-2 and cathepsin D in node-negative invasive breast cancer: their impact on the selection of patients for systemic adjuvant therapy.
    Tonkin KS; McKay JW; Stitt LW; Tokmakejian S; Haines DS
    Cancer Prev Control; 1999 Apr; 3(2):131-6. PubMed ID: 10474760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative prognostic value of Cathepsin D and urokinase plasminogen activator, detected by immunohistochemistry, in primary breast carcinoma.
    Göhring UJ; Scharl A; Thelen U; Ahr A; Crombach G
    Anticancer Res; 1996; 16(2):1011-8. PubMed ID: 8687092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer.
    Dowsett M; Dunbier AK
    Clin Cancer Res; 2008 Dec; 14(24):8019-26. PubMed ID: 19088018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancers.
    Peyrat JP; Vanlemmens L; Fournier J; Huet G; Révillion F; Bonneterre J
    Clin Cancer Res; 1998 Jan; 4(1):189-96. PubMed ID: 9516970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.